640735-27-9 Usage
Structure
Brominated pyrrolopyridine derivative with a pyrrole ring fused to a pyridine ring
Usage
Building block for the synthesis of biologically active compounds, such as potential drug candidates in the pharmaceutical industry
Importance
Unique structure and reactivity make it an important intermediate in organic synthesis, with applications in medicinal chemistry and drug discovery
Potential uses
Materials science or agrochemicals due to versatile nature and potential for functionalization.
Check Digit Verification of cas no
The CAS Registry Mumber 640735-27-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,4,0,7,3 and 5 respectively; the second part has 2 digits, 2 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 640735-27:
(8*6)+(7*4)+(6*0)+(5*7)+(4*3)+(3*5)+(2*2)+(1*7)=149
149 % 10 = 9
So 640735-27-9 is a valid CAS Registry Number.
640735-27-9Relevant articles and documents
HETEROCYCLIC INHIBITORS OF ATR KINASE
-
Paragraph 0693-0695, (2019/02/28)
The present invention relates to heterocyclic compounds and methods which may be useful as inhibitors of ATR kinase for the treatment or prevention of cancer.
MUSCARINIC M1 RECEPTOR POSITIVE ALLOSTERIC MODULATORS
-
Page/Page column 57, (2018/03/25)
The present invention relates to compounds of formula (I), or their isotopic forms, stereoisomers, tautomers or pharmaceutically acceptable salt (s) thereof as muscarinic M1 receptor positive allosteric modulators (M1 PAMs). The present invention describes the preparation, pharmaceutical composition and the use of compound formula (I).
NOVEL COMPOUNDS
-
Page/Page column 44, (2013/02/27)
The present invention relates to novel NADPH oxidase II inhibitors and their use in the treatment of diseases mediated by the NADPH oxidase enzymes.
